To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)

Clinical trial NCT07291921 · RECRUITING

Trial details

NCT number: NCT07291921
Sponsor: Peking University People's Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Neoplasms Neoadjuvant Therapy Immunotherapy Minimal Residual Disease

Start date: 2025-05-08
Primary completion: 2027-10-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.